Patents by Inventor JOHN SANGER
JOHN SANGER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11932536Abstract: A process for on-site hydrogen reforming is disclosed. The process includes providing a combined reformer heat exchanger component in which heated air, steam, and hydrocarbon fuel react to form process gas containing hydrogen, and the process gas is cooled via the heat exchanger. The combined components enable reductions in size, materials, costs, and heat loss. Additionally, as the heat exchanger side of the component operates at a cooler temperature, an uninsulated flange for access to the catalyst chamber can be used. A combined combustion heat exchanger component is also provided with similar advantages. Process gas is processed, and hydrogen gas is produced via a purification process.Type: GrantFiled: August 13, 2020Date of Patent: March 19, 2024Inventor: Robert John Sanger
-
Patent number: 11588652Abstract: Improved systems, methods, and architectures to enhance decision making in Smart Cities and Smart Regions. A system includes an index structure including a first hierarchical data structure including a first hierarchical score based on a plurality of first-level elements, each of the plurality of first-level elements having a respective weighting, and a second hierarchical data structure including a plurality of second hierarchical scores based on a plurality of second-level elements, each of the plurality of second-level elements having a respective weighting, such that the first hierarchical score is based on the plurality of second hierarchical scores through an index factor; and a computer-implemented regional monitor engine to manage local access to a plurality of external data sources to coordinate writes to the index structure.Type: GrantFiled: December 6, 2021Date of Patent: February 21, 2023Assignee: Tele-Commuter Resources, Inc.Inventor: John Sanger
-
Publication number: 20220200839Abstract: Improved systems, methods, and architectures to enhance decision making in Smart Cities and Smart Regions. A system includes an index structure including a first hierarchical data structure including a first hierarchical score based on a plurality of first-level elements, each of the plurality of first-level elements having a respective weighting, and a second hierarchical data structure including a plurality of second hierarchical scores based on a plurality of second-level elements, each of the plurality of second-level elements having a respective weighting, such that the first hierarchical score is based on the plurality of second hierarchical scores through an index factor; and a computer-implemented regional monitor engine to manage local access to a plurality of external data sources to coordinate writes to the index structure.Type: ApplicationFiled: December 6, 2021Publication date: June 23, 2022Inventor: John Sanger
-
Patent number: 11211171Abstract: Improved systems, methods, and architectures to enhance decision making in Smart Cities and Smart Regions. A system includes an index structure including a first hierarchical data structure including a first hierarchical score based on a plurality of first-level elements, each of the plurality of first-level elements having a respective weighting, and a second hierarchical data structure including a plurality of second hierarchical scores based on a plurality of second-level elements, each of the plurality of second-level elements having a respective weighting, such that the first hierarchical score is based on the plurality of second hierarchical scores through an index factor; and a computer-implemented regional monitor engine to manage local access to a plurality of external data sources to coordinate writes to the index structure.Type: GrantFiled: January 10, 2020Date of Patent: December 28, 2021Assignee: TELE-COMMUTER RESOURCES, INC.Inventor: John Sanger
-
Publication number: 20210002133Abstract: A process for on-site hydrogen reforming is disclosed. The process includes providing a combined reformer heat exchanger component in which heated air, steam, and hydrocarbon fuel react to form process gas containing hydrogen, and the process gas is cooled via the heat exchanger. The combined components enable reductions in size, materials, costs, and heat loss. Additionally, as the heat exchanger side of the component operates at a cooler temperature, an uninsulated flange for access to the catalyst chamber can be used. A combined combustion heat exchanger component is also provided with similar advantages. Process gas is processed, and hydrogen gas is produced via a purification process.Type: ApplicationFiled: August 13, 2020Publication date: January 7, 2021Inventor: Robert John Sanger
-
Publication number: 20210004752Abstract: A system and method for developing and implementing a workforce virtualization program comprises six phases. A virtualization assessment and profiling process uses analytic methods to determine the feasibility of virtualizing some or all of an organization's workers. A mitigation assessment is conducted to identify cost-effective means of reducing barriers to virtualization. Scenario assessment and modeling phase allows an organization to develop an optimum virtualization scenario. A policy review and development phase allows an organization to develop virtualization policies, including business continuity plans. A virtualization implementation planning phase allows and organization to develop detailed plans for deployment of the virtualization scenario. A monitoring and refinement process allows an organization to track implementation of the deployment plans and modify as necessary.Type: ApplicationFiled: September 22, 2020Publication date: January 7, 2021Inventor: John Sanger
-
Patent number: 10783468Abstract: A system and method for developing and implementing a workforce virtualization program comprises six phases. A virtualization assessment and profiling process uses analytic methods to determine the feasibility of virtualizing some or all of an organization's workers. A mitigation assessment is conducted to identify cost-effective means of reducing barriers to virtualization. Scenario assessment and modeling phase allows an organization to develop an optimum virtualization scenario. A policy review and development phase allows an organization to develop virtualization policies, including business continuity plans. A virtualization implementation planning phase allows and organization to develop detailed plans for deployment of the virtualization scenario. A monitoring and refinement process allows an organization to track implementation of the deployment plans and modify as necessary.Type: GrantFiled: December 11, 2015Date of Patent: September 22, 2020Inventor: John Sanger
-
Publication number: 20200227177Abstract: Improved systems, methods, and architectures to enhance decision making in Smart Cities and Smart Regions. A system includes an index structure including a first hierarchical data structure including a first hierarchical score based on a plurality of first-level elements, each of the plurality of first-level elements having a respective weighting, and a second hierarchical data structure including a plurality of second hierarchical scores based on a plurality of second-level elements, each of the plurality of second-level elements having a respective weighting, such that the first hierarchical score is based on the plurality of second hierarchical scores through an index factor; and a computer-implemented regional monitor engine to manage local access to a plurality of external data sources to coordinate writes to the index structure.Type: ApplicationFiled: January 10, 2020Publication date: July 16, 2020Inventor: John Sanger
-
Publication number: 20160171425Abstract: A system and method for developing and implementing a workforce virtualization program comprises six phases. A virtualization assessment and profiling process uses analytic methods to determine the feasibility of virtualizing some or all of an organization's workers. A mitigation assessment is conducted to identify cost-effective means of reducing barriers to virtualization. Scenario assessment and modeling phase allows an organization to develop an optimum virtualization scenario. A policy review and development phase allows an organization to develop virtualization policies, including business continuity plans. A virtualization implementation planning phase allows and organization to develop detailed plans for deployment of the virtualization scenario. A monitoring and refinement process allows an organization to track implementation of the deployment plans and modify as necessary.Type: ApplicationFiled: December 11, 2015Publication date: June 16, 2016Inventor: JOHN SANGER
-
Publication number: 20040152727Abstract: A method for the treatment and/or prophylaxis of conditions characterised by altered bowel function and/or visceral pain in humans or non-human mammals, which method comprises the administration of an effective, non-toxic and pharmaceutically acceptable amount of an NK3 receptor antagonist, wherein the condition characterised by altered bowel function and/or visceral pain is selected from certain irritable bowel syndrome conditions, functional abdominal bloating, functional constipation, functional diarrhea, other bowel conditions and functional abdominal pain.Type: ApplicationFiled: November 18, 2003Publication date: August 5, 2004Inventors: Douglas William Pierre Hay, Gareth John Sanger, Tadataka Yamada
-
Patent number: 6750195Abstract: A compound which acts as an antagonist at 5-HT4 receptors is of potential use in the treatment of conditions associated with bladder hypersensitivity, such as urinary incontinence, which is often associated with irritable bowel syndrome (IBS) and a compound which acts as an agonist at 5-HT4 receptors is of potential use in the treatment of conditions associated with a poorly functioning bladder, such as urinary bladder hypoactivity following prostectomy.Type: GrantFiled: September 27, 2002Date of Patent: June 15, 2004Assignee: SmithKline Beecham Corporation p.l.c.Inventors: Gareth John Sanger, Kay Alison Wardle
-
Publication number: 20030045452Abstract: A compound which acts as an antagonist at 5-HT4 receptors is of potential use in the treatment of conditions associated with bladder hypersensitivity, such as urinary incontinence, which is often associated with irritable bowel syndrome (IBS) and a compound which acts as an agonist at 5-HT4 receptors is of potential use in the treatment of conditions associated with a poorly functioning bladder, such as urinary bladder hypoactivity following prostectomy.Type: ApplicationFiled: September 27, 2002Publication date: March 6, 2003Applicant: SmithKline Beecham PLCInventors: Gareth John Sanger, Kay Alison Wardle
-
Patent number: 6506774Abstract: The use of orexin receptor antagonists as neuroprotectants, and in the treatment of nausea and vomiting, irritable bowel syndrome and other conditions associated with visceral pain.Type: GrantFiled: November 30, 2001Date of Patent: January 14, 2003Assignee: SmithKline Beecham p.l.c.Inventors: Elaine Alison Irving, Gareth John Sanger
-
Publication number: 20020128172Abstract: A compound which acts as an antagonist at 5-HT4 receptors is of potential use in the treatment of conditions associated with bladder hypersensitivity, such as urinary incontinence, which is often associated with irritable bowel syndrome (IBS) and a compound which acts as an agonist at 5-HT4 receptors is of potential use in the treatment of conditions associated with a poorly functioning bladder, such as urinary bladder hypoactivity following prostectomy.Type: ApplicationFiled: October 2, 2001Publication date: September 12, 2002Applicant: SmithKline Beecham PLCInventors: Gareth John Sanger, Kay Alison Wardle
-
Publication number: 20020019519Abstract: The use of KIAA0551 polypeptides and polynucleotides in the design of protocols for the treatment of neuropathies, neuropathic pain, inflammatory and chronic pain, neurodegenerative conditions such as Motor Neuron Disease, Parkinson's Disease, Alzheimer's Disease and other dementias, as well as ischaemic damage in neuronal and cardiac tissues, through disease or infectious agents, among others, and diagnostic assays for such conditions. Also disclosed are methods for producing such polypeptides by recombinant techniques.Type: ApplicationFiled: June 1, 2001Publication date: February 14, 2002Inventors: Sharon Bingham, Patrick Case, Sally Neale Lawson, Richard Anthony Newton, Oliver Lars Rausch, Alastair David Reith, Gareth John Sanger
-
Patent number: 6277979Abstract: The use of KIAA0551 polypeptides and polynucleotides in the design of protocols for the treatment of neuropathies, neuropathic pain, inflammatory and chronic pain, neurodegenerative conditions such as Motor Neuron Disease, Parkinson's Disease, Alzheimer's Disease and other dementias, as well as ischaemic damage in neuronal and cardiac tissues, through disease or infectious agents, among others, and diagnostic assays for such conditions. Also disclosed are methods for producing such polypeptides by recombinant techniques.Type: GrantFiled: September 10, 1999Date of Patent: August 21, 2001Assignee: SmithKline Beecham plcInventors: Sharon Bingham, Patrick Case, Sally Neale Lawson, Richard Anthony Newton, Oliver Lars Rausch, Alastair David Reith, Gareth John Sanger
-
Patent number: 6059961Abstract: A process and arrangement for contacting a moving bed of compact particulate material, usually catalyst, with a radial flow of fluid maintains an unconfined surface of catalyst particles in place by passing fluid axially into the upper surface of the bed and maintaining radial gas flow across an inlet screen at an elevation that is above the upper most elevation of perforations for withdrawing gas flow from the particulate bed. Two vertical screens confine the bed of catalyst. Perforations cover substantially the entire length of the inlet screen. The outlet portion of the screen has perforations that end below the top of the free surface of the catalyst bed and define an upper bed portion therebetween. The inlet screen directs gas flow radially across the inlet screen into an upper portion of the bed and cause at least partial axial flow of gas through the upper portion of the particle bed.Type: GrantFiled: April 27, 1998Date of Patent: May 9, 2000Assignee: UOP LLCInventors: William John Koves, Gary Alan Schulz, Robert John Sanger
-
Patent number: 5952340Abstract: The present invention is directed to a method for the treatment of post-operative nausea and vomiting wherein granisetron is administered to a patient in need thereof.Type: GrantFiled: May 23, 1996Date of Patent: September 14, 1999Assignee: SmithKLine Beecham p.l.c.Inventors: Gareth John Sanger, Philip Timothy Davey, Christopher Stuart Dott
-
Patent number: 5929059Abstract: A method of treatment of nausea and vomiting is disclosed which comprises administering to a human or animal subject granisetron and an antiemetic corticosteroid.Type: GrantFiled: July 28, 1997Date of Patent: July 27, 1999Assignee: SmithKline Beecham p.l.c.Inventors: Gareth John Sanger, Christopher Stuart Dott